nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR7—sympathetic nervous system—adrenal gland cancer	0.0727	0.204	CbGeAlD
Methysergide—HTR7—vein—adrenal gland cancer	0.068	0.191	CbGeAlD
Methysergide—HTR2A—sympathetic nervous system—adrenal gland cancer	0.0453	0.127	CbGeAlD
Methysergide—HTR2A—vein—adrenal gland cancer	0.0424	0.119	CbGeAlD
Methysergide—HTR2A—urine—adrenal gland cancer	0.0248	0.0698	CbGeAlD
Methysergide—Ergonovine—ABCB1—adrenal gland cancer	0.0131	0.475	CrCbGaD
Methysergide—SIGMAR1—adrenal cortex—adrenal gland cancer	0.0123	0.0347	CbGeAlD
Methysergide—HTR2B—adrenal cortex—adrenal gland cancer	0.0123	0.0346	CbGeAlD
Methysergide—SIGMAR1—cardiac atrium—adrenal gland cancer	0.0102	0.0287	CbGeAlD
Methysergide—SIGMAR1—pituitary gland—adrenal gland cancer	0.00998	0.028	CbGeAlD
Methysergide—SIGMAR1—adrenal gland—adrenal gland cancer	0.00891	0.0251	CbGeAlD
Methysergide—HTR2B—adrenal gland—adrenal gland cancer	0.00889	0.025	CbGeAlD
Methysergide—HTR7—gonad—adrenal gland cancer	0.00874	0.0246	CbGeAlD
Methysergide—HTR1A—adrenal gland—adrenal gland cancer	0.00797	0.0224	CbGeAlD
Methysergide—HTR7—adrenal gland—adrenal gland cancer	0.00762	0.0214	CbGeAlD
Methysergide—Ergotamine—ABCB1—adrenal gland cancer	0.0074	0.267	CrCbGaD
Methysergide—Bromocriptine—ABCB1—adrenal gland cancer	0.00713	0.258	CrCbGaD
Methysergide—HTR2A—gonad—adrenal gland cancer	0.00545	0.0153	CbGeAlD
Methysergide—HTR2A—pituitary gland—adrenal gland cancer	0.00532	0.0149	CbGeAlD
Methysergide—HTR2A—adrenal gland—adrenal gland cancer	0.00475	0.0134	CbGeAlD
Methysergide—HTR6—GPCR ligand binding—POMC—adrenal gland cancer	0.000753	0.00122	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—POMC—adrenal gland cancer	0.000752	0.00122	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000751	0.00122	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000748	0.00121	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—POMC—adrenal gland cancer	0.000747	0.00121	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000732	0.00119	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	0.000732	0.00119	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000731	0.00118	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000728	0.00118	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.000727	0.00118	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000715	0.00116	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000708	0.00115	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000708	0.00115	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000708	0.00115	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000706	0.00115	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000703	0.00114	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000703	0.00114	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000698	0.00113	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000695	0.00113	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000689	0.00112	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000688	0.00112	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	0.000688	0.00112	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—TP53—adrenal gland cancer	0.000668	0.00108	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000662	0.00107	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000661	0.00107	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—POMC—adrenal gland cancer	0.000661	0.00107	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000657	0.00106	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—GNRH1—adrenal gland cancer	0.000654	0.00106	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—GNRH1—adrenal gland cancer	0.000653	0.00106	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PRKACA—adrenal gland cancer	0.000649	0.00105	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000649	0.00105	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.000649	0.00105	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000647	0.00105	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000643	0.00104	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000636	0.00103	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000633	0.00103	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000632	0.00103	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000631	0.00102	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000631	0.00102	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000627	0.00102	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—POMC—adrenal gland cancer	0.000623	0.00101	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000614	0.000996	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PRKACA—adrenal gland cancer	0.000613	0.000993	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00061	0.00099	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000604	0.000979	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CDC42—adrenal gland cancer	0.000601	0.000974	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CDC42—adrenal gland cancer	0.0006	0.000973	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—POMC—adrenal gland cancer	0.0006	0.000973	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SPRY2—adrenal gland cancer	0.000598	0.00097	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SPRY2—adrenal gland cancer	0.000598	0.000969	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000597	0.000968	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.000596	0.000967	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.000594	0.000963	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000584	0.000947	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TSHR—adrenal gland cancer	0.000583	0.000946	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TSHR—adrenal gland cancer	0.000582	0.000944	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000581	0.000943	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TSHR—adrenal gland cancer	0.000579	0.000938	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000577	0.000936	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—GNAS—adrenal gland cancer	0.000574	0.000931	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—GNAS—adrenal gland cancer	0.000573	0.00093	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00057	0.000924	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000567	0.000919	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—POMC—adrenal gland cancer	0.000566	0.000918	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000558	0.000905	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000558	0.000904	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000556	0.000902	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	0.000555	0.0009	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CDC42—adrenal gland cancer	0.000551	0.000893	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000548	0.000889	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MEN1—adrenal gland cancer	0.000548	0.000889	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MEN1—adrenal gland cancer	0.000548	0.000888	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000546	0.000886	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MEN1—adrenal gland cancer	0.000544	0.000882	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000533	0.000864	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	0.000532	0.000863	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF2—adrenal gland cancer	0.000531	0.000861	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—GNAS—adrenal gland cancer	0.000526	0.000854	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000524	0.00085	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000524	0.00085	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000522	0.000846	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CDC42—adrenal gland cancer	0.00052	0.000843	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF1R—adrenal gland cancer	0.000513	0.000832	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF2—adrenal gland cancer	0.000501	0.000812	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	0.0005	0.000811	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—GNAS—adrenal gland cancer	0.000496	0.000805	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00049	0.000794	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000487	0.00079	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000484	0.000785	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF1R—adrenal gland cancer	0.000484	0.000785	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000483	0.000783	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000482	0.000781	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000482	0.000781	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000468	0.000759	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000466	0.000755	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000453	0.000735	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000445	0.000721	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000443	0.000718	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000442	0.000718	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TERT—adrenal gland cancer	0.000442	0.000717	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.000441	0.000715	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000432	0.0007	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000429	0.000696	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—POMC—adrenal gland cancer	0.000426	0.00069	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—POMC—adrenal gland cancer	0.000425	0.00069	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000425	0.000689	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000423	0.000686	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000423	0.000686	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000422	0.000685	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PRKACA—adrenal gland cancer	0.000418	0.000679	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000418	0.000678	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PRKACA—adrenal gland cancer	0.000418	0.000678	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TERT—adrenal gland cancer	0.000417	0.000676	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000415	0.000673	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000414	0.000671	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000407	0.000659	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000406	0.000658	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000404	0.000656	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000404	0.000655	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000389	0.00063	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—POMC—adrenal gland cancer	0.000387	0.000627	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—POMC—adrenal gland cancer	0.000386	0.000626	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—BAD—adrenal gland cancer	0.000384	0.000623	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000384	0.000623	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000384	0.000622	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000383	0.00062	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000382	0.000619	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000376	0.000609	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000373	0.000605	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000367	0.000595	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—BAD—adrenal gland cancer	0.000363	0.000588	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CDC42—adrenal gland cancer	0.000355	0.000576	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	0.000355	0.000575	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—POMC—adrenal gland cancer	0.000354	0.000575	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000353	0.000572	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000352	0.000571	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000351	0.000568	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—BRAF—adrenal gland cancer	0.00035	0.000567	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000345	0.000559	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF2—adrenal gland cancer	0.000342	0.000555	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	0.000342	0.000554	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000339	0.000551	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—EGFR—adrenal gland cancer	0.000339	0.00055	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—GNAS—adrenal gland cancer	0.000339	0.00055	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	0.000339	0.000549	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000337	0.000546	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—POMC—adrenal gland cancer	0.000334	0.000542	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000332	0.000539	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF1R—adrenal gland cancer	0.000331	0.000536	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	0.00033	0.000536	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—BRAF—adrenal gland cancer	0.00033	0.000535	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.00033	0.000534	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000328	0.000532	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000324	0.000525	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000321	0.000521	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—EGFR—adrenal gland cancer	0.00032	0.000519	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000315	0.000511	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000313	0.000508	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000312	0.000506	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00031	0.000502	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.00031	0.000502	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000308	0.0005	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000302	0.00049	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000286	0.000464	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TERT—adrenal gland cancer	0.000285	0.000462	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000285	0.000462	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TERT—adrenal gland cancer	0.000284	0.000461	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000283	0.000458	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000277	0.000449	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000272	0.000441	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000268	0.000434	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000263	0.000426	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000261	0.000424	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.00026	0.000421	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000253	0.000411	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000253	0.00041	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000252	0.000409	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000251	0.000407	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.00025	0.000405	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—BAD—adrenal gland cancer	0.000248	0.000402	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—BAD—adrenal gland cancer	0.000247	0.000401	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000247	0.000401	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000246	0.000399	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000245	0.000397	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000244	0.000395	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000241	0.00039	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000239	0.000387	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—adrenal gland cancer	0.000228	0.00037	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—adrenal gland cancer	0.000228	0.00037	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000227	0.000368	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000227	0.000368	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000226	0.000367	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	0.000225	0.000366	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	0.000225	0.000365	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000224	0.000363	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000222	0.00036	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000219	0.000355	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000219	0.000355	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	0.000219	0.000354	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	0.000218	0.000354	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000217	0.000352	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000217	0.000352	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000212	0.000344	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000212	0.000343	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000211	0.000342	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.00021	0.00034	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000208	0.000338	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000206	0.000334	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EGFR—adrenal gland cancer	0.0002	0.000325	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000199	0.000324	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EGFR—adrenal gland cancer	0.000189	0.000307	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000183	0.000297	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000182	0.000296	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000182	0.000295	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000169	0.000274	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TP53—adrenal gland cancer	0.000168	0.000273	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000168	0.000273	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000167	0.000271	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000166	0.000269	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000163	0.000264	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000163	0.000264	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000162	0.000262	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000162	0.000262	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000161	0.000261	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TP53—adrenal gland cancer	0.000159	0.000257	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000158	0.000257	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000158	0.000257	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000149	0.000241	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000146	0.000237	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000144	0.000234	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.00014	0.000227	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	0.000129	0.000209	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	0.000129	0.000209	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000128	0.000208	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000125	0.000203	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000121	0.000196	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00012	0.000195	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000118	0.000191	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TP53—adrenal gland cancer	0.000108	0.000176	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TP53—adrenal gland cancer	0.000108	0.000176	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	0.000108	0.000174	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	0.000105	0.000171	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000104	0.000169	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	9.89e-05	0.00016	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	9.56e-05	0.000155	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	9.51e-05	0.000154	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	8.26e-05	0.000134	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	8.02e-05	0.00013	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	7.98e-05	0.000129	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	6.93e-05	0.000112	CbGpPWpGaD
